FDA to miss approval deadline for Kalvista drug due to ‘resource constraints’

A “heavy workload” and “limited resources” have left the agency unable to meet a June 17 deadline to approve a therapy Kalvista has been developing for hereditary angioedema.

GROW Project launched to drive green jobs, sustainable construction in Africa – EnviroNews

February 26, 2026

Lilly to give biotech startups access to AI tools

Lilly’s GLP-1 pill tops Novo’s Rybelsus in head-to-head trial

February 26, 2026

Source link

FDA to miss approval deadline for Kalvista drug due to ‘resource constraints’

GROW Project launched to drive green jobs, sustainable construction in Africa – EnviroNews

Lilly’s GLP-1 pill tops Novo’s Rybelsus in head-to-head trial

Top 5 African cities with the smoothest traffic mid-2025

Meta buys stake in Scale AI, raising antitrust concerns

Meta buys stake in Scale AI, raising antitrust concerns

Leave a Reply Cancel reply

RECOMMENDED NEWS

Roblox Hits 77 Million Users. Here’s How It Keeps Growing

Drax rises on earnings beat, while biomass decision in limbo

What Are Safetensors in Stable Diffusion?

Ollin debuts with $100M and plans to challenge top-selling eye drugs

POPULAR NEWS

Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

The world’s top 10 most valuable car brands in 2025

Top 10 African countries with the highest GDP per capita in 2025

Global ranking of Top 5 smartphone brands in Q3, 2024

Mahama attends Liberia’s 178th independence anniversary

FDA to miss approval deadline for Kalvista drug due to ‘resource constraints’

Related posts

Top 5 African cities with the smoothest traffic mid-2025

Meta buys stake in Scale AI, raising antitrust concerns

Leave a Reply Cancel reply

RECOMMENDED NEWS

POPULAR NEWS